Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novartis AG Common Stock
(NY:
NVS
)
137.87
-0.85 (-0.61%)
Official Closing Price
Updated: 7:00 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
756,337
Open
138.71
Bid (Size)
130.00 (100)
Ask (Size)
140.01 (100)
Prev. Close
138.72
Today's Range
137.80 - 138.91
52wk Range
96.91 - 140.18
Shares Outstanding
N/A
Dividend Yield
2.90%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The $3 Billion Bet: How Isomorphic Labs is Rewriting the Rules of Drug Discovery with Eli Lilly and Novartis
January 01, 2026
In a move that has fundamentally reshaped the landscape of the pharmaceutical industry, Isomorphic Labs—the London-based drug discovery arm of Alphabet Inc. (NASDAQ: GOOGL)—has solidified its position...
Via
TokenRing AI
Topics
Artificial Intelligence
The Great Unlocking: How AlphaFold 3’s Open-Source Pivot Sparked a New Era of Drug Discovery
January 01, 2026
The landscape of biological science underwent a seismic shift in November 2024, when Google DeepMind, a subsidiary of Alphabet Inc. (NASDAQ: GOOGL), officially released the source code and model...
Via
TokenRing AI
Topics
Artificial Intelligence
Performance
YTD
N/A
N/A
1 Month
+4.2%
+4.2%
3 Month
+5.3%
+5.3%
6 Month
+13.1%
+13.1%
1 Year
+41.9%
+41.9%
More News
Read More
Novartis AG (NYSE:NVS) Stands Out as a Dependable Dividend Stock with Strong Fundamentals
↗
January 01, 2026
Via
Chartmill
Decoding Life’s Blueprint: How AlphaFold 3 is Redefining the Frontier of Medicine
December 31, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Bonds
Invest Outside the U.S. With These Top International ETFs
↗
December 31, 2025
Via
The Motley Fool
Topics
ETFs
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Pfizer Leads New Wave Of 2026 US Drug Price Hikes Despite Trump’s Drug Cost Crackdown: Report
↗
December 31, 2025
Via
Stocktwits
Topics
Economy
Government
The “Operating System of Life”: How AlphaFold 3 Redefined Biology and the Drug Discovery Frontier
December 30, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
AlphaFold’s Five-Year Reign: 3 Million Researchers and the Dawn of a New Biological Era
December 29, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Climate Change
Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
December 29, 2025
Via
MarketMinute
Topics
ETFs
Intellectual Property
Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Compelling Value Investment Case
↗
December 29, 2025
Via
Chartmill
The Biological Turing Point: How AlphaFold 3 and the Nobel Prize Redefined the Future of Medicine
December 25, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Initial Public Offering
Stock Market Today, Dec. 23: Novo Nordisk Surges After FDA Approves Oral Wegovy Weight Loss Pill
↗
December 23, 2025
Via
The Motley Fool
Topics
Stocks
The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally
December 22, 2025
Via
MarketMinute
Topics
ETFs
Economy
Intellectual Property
2 Top Stocks to Buy and Hold for the Long Term
↗
December 22, 2025
Via
The Motley Fool
Topics
Intellectual Property
Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants
↗
December 19, 2025
Via
Stocktwits
Topics
Government
World Trade
Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump
↗
December 19, 2025
Via
Investor's Business Daily
Topics
Government
Stocks
AbbVie, Merck, Other Top Drugmakers To Lower Prices Of US Drugs In MFN Deal With Trump Administration: Report
↗
December 19, 2025
Via
Stocktwits
Topics
Economy
Government
White House Readies Drug Price Deals With AbbVie, Novartis, Roche
↗
December 18, 2025
Via
Benzinga
Salesforce Stock Rises On BTIG Buy Rating And Novartis Agentforce Deal
↗
December 17, 2025
Via
Benzinga
Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks
↗
December 17, 2025
Via
Stocktwits
Topics
Government
World Trade
Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock with Strong Financials
↗
December 10, 2025
Via
Chartmill
Novartis' Investigational Drug Reports Longer Disease Control In Patients With Rare Blood Disorder
↗
December 09, 2025
Via
Benzinga
Silver Shines as Global Tariff Storm Gathers: A Safe-Haven and Strategic Imperative in 2025
December 09, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Energy
Can the Vanguard International High Dividend Yield Index Fund ETF Shares Outperform Again in 2026?
↗
December 07, 2025
Via
The Motley Fool
Topics
ETFs
Economy
Stocks
Frequently Asked Questions
Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 137.87
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 12/31/25 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.